Cargando…
An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
Growing evidence suggests that the superiority of long noncoding RNAs (lncRNAs) and messenger RNAs (mRNAs) could act as biomarkers for cancer prognosis. However, the prognostic marker for hepatocellular carcinoma with high accuracy and sensitivity is still lacking. In this research, a retrospective,...
Autores principales: | Zhu, Rui, Guo, Wenna, Xu, Xin-Jian, Zhu, Liucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655255/ https://www.ncbi.nlm.nih.gov/pubmed/33204302 http://dx.doi.org/10.1155/2020/8872329 |
Ejemplares similares
-
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019) -
A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma
por: Zhan, Yueping, et al.
Publicado: (2015) -
A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017) -
Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
por: Guo, Wenna, et al.
Publicado: (2022) -
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma
por: Du, Xuanlong, et al.
Publicado: (2020)